BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30
• 31

• Press Releases

  Organon to Report Third Quarter 2024 Results and Host Conference Call on October 31, 2024

  October 9, 2024

   · 

  3 min read
• Press Releases

  UroGen Appoints Chris Degnan as Chief Financial Officer

  October 9, 2024

   · 

  5 min read
• Press Releases

  bioAffinity Technologies Awarded U.S. Federal Supply Schedule Contract for CyPath® Lung Test

  October 9, 2024

   · 

  6 min read
• Press Releases

  Allurion Announces Publication of New Data Demonstrating Muscle Mass Preservation in Patients Experiencing 15% Weight Loss

  October 9, 2024

   · 

  4 min read
• Press Releases

  Arda Therapeutics Secures $43M Series A Financing to Advance Targeted Cell Depletion Therapies

  October 9, 2024

   · 

  4 min read
• Press Releases

  Kronos Bio to Present Data at the EORTC-NCI-AACR Symposium that Supports p300 KAT Inhibition in HPV-Driven Tumors

  October 9, 2024

   · 

  4 min read
• Press Releases

  Healgen’s At-Home COVID-19 and Influenza Test Achieves FDA De Novo Status with Key Support from CovarsaDx® Research Team

  October 9, 2024

   · 

  3 min read
• Press Releases

  NanoVibronix Takes Next Step to Partner with Specialist Urology Company to Expand Sales of UroShield in Germany

  October 9, 2024

   · 

  5 min read
• Press Releases

  Inhibikase Therapeutics Announces Pricing of $110 Million Private Placement to Advance IkT-001Pro, an Optimized Prodrug of Imatinib, into a Late-Stage Trial in Pulmonary Arterial Hypertension

  October 9, 2024

   · 

  7 min read
• Press Releases

  AIM ImmunoTech to Participate in the 2024 Healthcare Virtual Summit, Presented by Maxim Group LLC

  October 9, 2024

   · 

  1 min read